The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Nonsteroidal antiinflammatory drug resistance in dysmenorrhea: epidemiology, causes, and treatment
Open accessAbstract
&NA; Although nonsteroidal antiinflammatory drugs can alleviate menstrual pain, about 18% of women with dysmenorrhea are unresponsive, leaving them and their physicians to pursue less well‐studied strategies. The goal of this review is to provide a background for treating menstrual pain when first‐line options fail. Research on menstrual pain and failure of similar drugs in the antiplatelet category suggested potential mechanisms underlying nonsteroidal antiinflammatory drug resistance. Based on these mechanisms, alternative options may be helpful for refractory cases. This review also identifies key pathways in need of further study to optimize menstrual pain treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Brown, J., & Brown, S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004142.pub2 · Cited by 82
RetractedZanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169 · cited 1×
“CYP gain-of-function variants are associated with increased metabolism, resulting in decreased drug effect.(47) For example, the CYP2C9*2/*2 polymorphism was associated with increased total clearance of celecoxib and diclofenac.”
BackgroundESHRE guideline for the diagnosis and treatment of endometriosis
Kennedy, S., Bergqvist, A., Chapron, C., D’Hooghe, T., Dunselman, G., Greb, R., Hummelshoj, L., Prentice, A., & Saridogan, E. (2005) · Human Reproduction · doi:10.1093/humrep/dei135 · Cited by 1,584
Vercellini, P., Fedele, L., Aimi, G., Pietropaolo, G., Consonni, D., & Crosignani, P. G. (2007) · Human Reproduction · doi:10.1093/humrep/del339 · Cited by 547
Treatment of pelvic pain associated with endometriosis: a committee opinion
(2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.012 · Cited by 397
Practice Bulletin No. 114: Management of Endometriosis
(2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181e8b073 · Cited by 382
Strowitzki, T., Marr, J., Gerlinger, C., Faustmann, T., & Seitz, C. (2010) · Human Reproduction · doi:10.1093/humrep/dep469 · Cited by 381 · cited 1×
“APRIL 2018 Dienogest was also as effective in reducing menstrual pain when compared to the GnRH agonist leuprolide.(101) An open-label study found norethindrone acetate was as effective at reducing menstrual pain as OCPs.”
BackgroundProstaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells
Noble, L. S. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.600 · Cited by 301
Harada, T., Momoeda, M., Taketani, Y., Hoshiai, H., & Terakawa, N. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.08.051 · Cited by 289
As-Sanie, S., Harris, R. E., Napadow, V., Kim, J., Neshewat, G., Kairys, A., Williams, D., Clauw, D. J., & Schmidt-Wilcke, T. (2012) · Pain · doi:10.1016/j.pain.2012.01.032 · Cited by 268
Cited by
Primary Dysmenorrhea: Pathophysiology, Diagnosis, and Treatment Updates
Itani, R., Soubra, L., Karout, S., Rahme, D., Karout, L., & Khojah, H. M. J. (2022) · Korean Journal of Family Medicine · doi:10.4082/kjfm.21.0103 · Cited by 280
Inflammatory Markers in Dysmenorrhea and Therapeutic Options
Barcikowska, Z., Rajkowska-Labon, E., Grzybowska, M. E., Hansdorfer-Korzon, R., & Zorena, K. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17041191 · Cited by 269
Smartphone apps for menstrual pain and symptom management: a scoping review
Trépanier, L. C. M., Lamoureux, É., Bjornson, S. E., Mackie, C., Alberts, N. M., & Gagnon, M. M. (2023) · Internet Interventions · doi:10.1016/j.invent.2023.100605 · Cited by 50
Metadata
- Authors
- Oladosu, F. A., Tu, F. F., & Hellman, K. M.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 218
- Issue
- 4
- Pages
- 390-400
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W2752853294
- Cited by
- 218
- References
- 23
- FWCI
- 12.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nonsteroidal antiinflammatory drug resistance in dysmenorrhea: epidemiology, causes, and treatment. https://app.cochat.ai/papers/10.1016/j.ajog.2017.08.108
- The paper
- Oladosu, F. A., Tu, F. F., & Hellman, K. M. (2018). Nonsteroidal antiinflammatory drug resistance in dysmenorrhea: epidemiology, causes, and treatment. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2017.08.108
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.